Lista articolelor cu rezumate în limba engleza
Afisarea articolelor: 1-1(1)
2023
1. | Efficacy and safety of an inhaled pan-Janus kinase inhibitor, nezulcitinib, in hospitalised patients with COVID-19: results from a phase 2 clinical trial . BMJ Open Respiratory Research. 2023, nr. , 0-0. ISSN 2052-4439. (Cat. ) |
1-1 of 1